IntReALL 01.10.2011

International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardised diagnostic and research

IntReALL 2010 is embedded in a network of European academic structures relevant for childhood cancer. It will be a cornerstone of drug development in childhood leukaemia and the only trial with the potential for well-powered phase III studies in this indication. IntReALL 2010 will harmonise ALL-relapse therapy, establish highest diagnostic and therapeutic standard and improve survival of children with ALL.

The CCRI is a partner in this project and Assoc. Prof. Georg Mann, MD, and Assoc. Prof. Andishe Attarbaschi, MD, are the scientists in charge.